ReviewMedical science monitor : international medical journal of experimental and clinical research2026
Review of the Composition and Antimicrobial Roles of Extracts of Vine Tea (Ampelopsis grossedentata).
Review in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vine tea (Ampelopsis grossedentata) is a traditional medicinal and edible plant widely consumed in China. Its bioactivity is attributed to flavonoids, particularly dihydromyricetin, which exhibits broad-spectrum antimicrobial activities. This review provides a comprehensive narrative synthesis of the antimicrobial properties of dihydromyricetin from vine tea against pathogenic bacteria and fungi, underlying mechanisms of action, and potential applications. Current evidence indicates that dihydromyricetin exerts antimicrobial effects through multiple mechanisms, including disruption of cell wall integrity, alteration of membrane permeability, interference with lipid and energy metabolism, inhibition of protein synthesis, and suppression of virulence-associated processes. Notably, its antibacterial activity is generally more pronounced against gram-positive bacteria than gram-negative species, while antifungal efficacy is comparatively weaker but can be significantly enhanced through advanced formulation strategies, including co-crystallization and nanoparticle-based delivery systems. Moreover, dihydromyricetin demonstrates a multi-target, multi-pathway mode of action, involving key metabolic and signaling pathways related to oxidative stress, inflammation, and cellular homeostasis. Despite its promising antimicrobial potential, current research is limited by methodological inconsistencies, including reliance on inhibition-zone assays, insufficient reporting of minimum inhibitory concentrations, and lack of standardized experimental frameworks. Furthermore, data on toxicity, bioavailability, and real-world application remain inadequate. Overall, dihydromyricetin represents a promising natural antimicrobial agent with potential applications in food preservation, agriculture, and pharmaceuticals. Future research should prioritize standardized evaluation methods, comprehensive toxicological assessment, and the development of effective delivery systems to facilitate its translation from laboratory studies to practical applications. This article aims to review the composition and antimicrobial roles of extracts of vine tea (A. grossedentata).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.